Home

Piramal Pharma Limited

NSE: PPLPHARMA

₹216.66
+3.35%
EOD snapshot

About Piramal Pharma Limited

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing; offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain management drugs, and other generic and speciality products; and analgesics, skin care, vitamin and mineral supplement, kids' wellness, digestives, and women's health, as well as geriatric care. The company was incorporated in 2020 and is based in Mumbai, India.

Healthcare · Drug Manufacturers - Specialty & Generic

Full scanner analysis & price chartMembers

Results

No scheduled results found for PPLPHARMA.

Historical quarterly results aren't available in the current data feed.

Corporate Actions

No recent corporate actions for PPLPHARMA.

Latest News · Piramal Pharma Limited

Loading news…

More in Healthcare

All companies, by sector

Company overview assembled from NSE results / corporate-action feeds and market news. Not investment advice.